货号:A449367 同义名: 氨基己酸 / EACA;Epsilon-Amino-n-caproic Acid
6-Aminocaproic Acid inhibits the plasmin activating enzymes streptokinase, fibrinokinase and urokinase, it is an antifibrinolytic agent.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | 6-Aminocaproic acid (EACA), a monoamino carboxylic acid, acts as a potent oral inhibitor of plasmin and plasminogen. It serves as a powerful antifibrinolytic agent by preventing clot lysis through competitive binding to lysine residues on plasminogen, inhibiting plasmin formation, and thereby reducing fibrinolysis. This compound is researched for use in treating bleeding disorders[1].[2]. |
体内研究 | Furthermore, 6-Aminocaproic acid administered orally in doses ranging from 20 to 100 mg/kg inhibits fibrinolysis in dogs across all doses tested. It is rapidly absorbed with a Tmax of approximately 1 hour and is quickly eliminated, indicating its fast-acting nature in clinical applications[3]. |
体外研究 | In studies involving Asian elephants, 6-Aminocaproic acid at concentrations between 20 to 180 μg/mL effectively inhibits fibrinolysis in plasma, with an effective concentration of 61.5 μg/mL[2]. It is also employed as a hydrophobic linker to enhance the efficacy of PEGylated indocyanine green for applications in near-infrared fluorescence imaging and photothermal cancer therapy[4]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01968070 | Healthy Volunteers | Phase 1 | Completed | - | United States, Indiana ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Evansville, Indiana, United States, 47710 收起 << |
NCT03364491 | Obstetrical Complications ... 展开 >> Hemorrhage Labor and Delivery 收起 << | Phase 3 | Recruiting | December 2020 | United States, Alabama ... 展开 >> University of Alabama - Birmingham Recruiting Birmingham, Alabama, United States, 35233 Contact: Stacy Harris, BSN 205-996-6262 stacylharris@uabmc.edu Principal Investigator: Alan TN Tita, MD United States, Illinois Northwestern University-Prentice Hospital Recruiting Chicago, Illinois, United States, 60611 Contact: Gail Mallett, RN BSN CCRC 312-503-3200 g-mallett@northwestern.edu Principal Investigator: William Grobman, MD United States, New York Columbia University Recruiting New York, New York, United States, 10032 Contact: Sabine Bousleiman 212-305-4348 sb1080@columbia.edu Principal Investigator: Cynthia Gyamfi-Bannerman, MD United States, North Carolina University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Kelly Clark, RN 919-350-6117 kelly_clark@med.unc.edu Principal Investigator: John M Thorp, Jr., MD United States, Ohio Case Western Reserve-MetroHealth Recruiting Cleveland, Ohio, United States, 44109 Contact: Wendy Dalton, RN 216-778-7533 wdalton@metrohealth.org Principal Investigator: Edward Chien, MD Ohio State University Hospital Recruiting Columbus, Ohio, United States, 43210 Contact: Anna Bartholomew, RN, BSN 614-685-3229 anna.bartholomew@osumc.edu Principal Investigator: Catalin S Buhimschi, MD United States, Pennsylvania Hospital of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Jennifer Craig, BSN 212-662-3926 jennifer.craig@uphs.upenn.edu Principal Investigator: Samuel Parry, MD Magee Women's Hospital of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Melissa Bickus, BS, RN 412-641-4072 mbickus@mail.magee.edu Principal Investigator: Hyagriv Simhan, MD, MS United States, Rhode Island Brown University Recruiting Providence, Rhode Island, United States, 02905 Contact: Donna Allard, RNC 401-274-1122 dallard@wihri.org Principal Investigator: Dwight J Rouse, MD United States, Texas University of Texas Medical Branch Recruiting Galveston, Texas, United States, 77555 Contact: Ashley Salazar, MSN 409-772-0312 assalaza@utmb.edu Principal Investigator: George R Saade, MD University of Texas - Houston Recruiting Houston, Texas, United States, 77030 Contact: Felecia Ortiz, RN BSN 713-500-6467 Felecia.Ortiz@uth.tmc.edu Principal Investigator: Suneet Chauhan, MD United States, Utah University of Utah Medical Center Recruiting Salt Lake City, Utah, United States, 84132 Contact: Kim Hill, RN 801-585-7645 Kim.Hill@hsc.utah.edu Principal Investigator: Michael W Varner, MD 收起 << |
NCT01428713 | Menorrhagia | Not Applicable | Completed | - | United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
7.62mL 1.52mL 0.76mL |
38.12mL 7.62mL 3.81mL |
76.24mL 15.25mL 7.62mL |
CAS号 | 60-32-2 |
分子式 | C6H13NO2 |
分子量 | 131.173 |
别名 | 氨基己酸 ;EACA;Epsilon-Amino-n-caproic Acid;Hepin;Capracid;Aminocaproic acid;NSC 400230;NSC 212532;NSC 26154;ε-Aminocaproic Acid;(6-)ε-Aminocaproic acid;6-Aminohexanoic acid |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Sealed in dry,Room Temperature |
溶解度 |
H2O: 50 mg/mL(381.18 mM) |
动物实验配方 |